Reg 24(A)
Awaiting price reaction for this filing.
Dolphin Medical Services has submitted its Annual Secretarial Compliance Report to BSE for the financial year ended 31 March 2025, as required under Regulation 24(A) of SEBI's Listing Rules. The report, certified by Practicing Company Secretary CS Bharatiraju Vegiraju, confirms full compliance across all 12 areas reviewed, including secretarial standards, board policies, website disclosures, director eligibility, related party transactions, and insider trading norms. No action was taken by SEBI or stock exchanges against the company, its promoters, or directors during the year, and no additional non-compliances were flagged. The only notable corporate event is that the statutory auditor resigned within 45 days of a quarter end, and a new auditor was appointed on 15 March 2025. The report carries no penalties, qualifications, or adverse remarks.
This is a routine yearly compliance filing with a clean bill of health — no regulatory actions, penalties, or governance red flags were reported. For shareholders, it signals continued adherence to listing requirements with no immediate negative implications for the stock.